SciSparc diversified its portfolio in the Israeli market and expanded into the automotive sector via AutoMax.
3 reports, 1 independent
Updated Aug 28
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
SciSparc diversified its portfolio in the Israeli market and expanded into the automotive sector via AutoMax.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
SciSparc
pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireSciSparc: AutoMax’s Shareholders Approve Merger with SciSparc TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stag
- GlobeNewswireSciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"),
- GlobeNewswireSciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPR